Literature DB >> 26974458

Systematic Bias in Meta-Analyses of Time to Antimicrobial in Sepsis Studies.

Anand Kumar1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26974458     DOI: 10.1097/CCM.0000000000001512

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  10 in total

1.  The Surviving Sepsis Campaign Bundle: 2018 update.

Authors:  Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2018-04-19       Impact factor: 17.440

2.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

3.  The authors reply.

Authors:  Sarah A Sterling; Michael A Puskarich; Alan E Jones
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

4.  Imipenem-induced paroxysmal supraventricular tachycardia in a sepsis patient.

Authors:  Vanita Ahuja; Harjit Sharma; Vaishali Singla
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-07-15

Review 5.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

6.  Prevalence and Prognostic Impact of Hypernatremia in Sepsis and Septic Shock Patients in the Intensive Care Unit: A Single Centre Experience.

Authors:  Mohamed Shirazy; Islam Omar; Duaa Abduljabbar; Kamel Bousselmi; Maryam Alkhaja; Anis Chaari; Vipin Kauts; Karim Hakim
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-01-31

7.  Epidemiology and risk factors of candidemia due to Candida parapsilosis in an intensive care unit.

Authors:  Xiao-Shu Zuo; Yanan Liu; Ke Hu
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-03-24       Impact factor: 1.846

8.  Compliance with the Surviving Sepsis Campaign guideline 1-hour bundle for septic shock in China in 2018.

Authors:  Lu Wang; Xudong Ma; Huaiwu He; Longxiang Su; Yanhong Guo; Guangliang Shan; Ye Wang; Xiang Zhou; Dawei Liu; Yun Long
Journal:  Ann Transl Med       Date:  2021-02

9.  Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers.

Authors:  Isabela Borges; Rafael Carneiro; Rafael Bergo; Larissa Martins; Enrico Colosimo; Carolina Oliveira; Saulo Saturnino; Marcus Vinícius Andrade; Cecilia Ravetti; Vandack Nobre
Journal:  Crit Care       Date:  2020-06-01       Impact factor: 9.097

10.  A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.

Authors:  Donna M Wolk; Stephen Young; Natalie N Whitfield; Jennifer L Reid; Adam Thornberg; Karen C Carroll; Blake W Buchan; Thomas E Davis; Hossein Salimnia
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.